SE520150C2 - Quantitative and qualitative analysis of chemical substances - Google Patents
Quantitative and qualitative analysis of chemical substancesInfo
- Publication number
- SE520150C2 SE520150C2 SE9502902A SE9502902A SE520150C2 SE 520150 C2 SE520150 C2 SE 520150C2 SE 9502902 A SE9502902 A SE 9502902A SE 9502902 A SE9502902 A SE 9502902A SE 520150 C2 SE520150 C2 SE 520150C2
- Authority
- SE
- Sweden
- Prior art keywords
- analyte
- recognition component
- magnetic permeability
- marker
- binding
- Prior art date
Links
- 239000000126 substance Substances 0.000 title claims abstract description 18
- 238000004451 qualitative analysis Methods 0.000 title 1
- 238000004445 quantitative analysis Methods 0.000 title 1
- 239000012491 analyte Substances 0.000 claims abstract description 48
- 230000005291 magnetic effect Effects 0.000 claims abstract description 44
- 230000035699 permeability Effects 0.000 claims abstract description 30
- 239000003550 marker Substances 0.000 claims abstract description 29
- 230000027455 binding Effects 0.000 claims abstract description 14
- 239000000463 material Substances 0.000 claims abstract description 13
- 238000004458 analytical method Methods 0.000 claims abstract description 9
- 230000001939 inductive effect Effects 0.000 claims abstract description 7
- 238000005259 measurement Methods 0.000 claims description 34
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 15
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 14
- 239000008103 glucose Substances 0.000 claims description 14
- 229910052742 iron Inorganic materials 0.000 claims description 11
- 241000894006 Bacteria Species 0.000 claims description 5
- 230000008859 change Effects 0.000 claims description 5
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 4
- 230000002860 competitive effect Effects 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 3
- 239000000427 antigen Substances 0.000 claims description 2
- 108091007433 antigens Proteins 0.000 claims description 2
- 102000036639 antigens Human genes 0.000 claims description 2
- 238000005516 engineering process Methods 0.000 claims description 2
- 238000011534 incubation Methods 0.000 claims description 2
- 229910052759 nickel Inorganic materials 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims 2
- 239000000284 extract Substances 0.000 claims 2
- 238000004401 flow injection analysis Methods 0.000 claims 2
- 241000233866 Fungi Species 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 241000580858 Simian-Human immunodeficiency virus Species 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 239000000956 alloy Substances 0.000 claims 1
- 229910045601 alloy Inorganic materials 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000001124 body fluid Anatomy 0.000 claims 1
- 239000010839 body fluid Substances 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000010941 cobalt Substances 0.000 claims 1
- 229910017052 cobalt Inorganic materials 0.000 claims 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 230000008878 coupling Effects 0.000 claims 1
- 238000010168 coupling process Methods 0.000 claims 1
- 238000005859 coupling reaction Methods 0.000 claims 1
- 230000007123 defense Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 230000007613 environmental effect Effects 0.000 claims 1
- 210000003608 fece Anatomy 0.000 claims 1
- 125000000524 functional group Chemical group 0.000 claims 1
- 239000005556 hormone Substances 0.000 claims 1
- 229940088597 hormone Drugs 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 230000002209 hydrophobic effect Effects 0.000 claims 1
- 238000002847 impedance measurement Methods 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims 1
- 239000002207 metabolite Substances 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- 210000002381 plasma Anatomy 0.000 claims 1
- 210000003296 saliva Anatomy 0.000 claims 1
- 239000004065 semiconductor Substances 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 210000004243 sweat Anatomy 0.000 claims 1
- 210000001138 tear Anatomy 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
- 239000003053 toxin Substances 0.000 claims 1
- 231100000765 toxin Toxicity 0.000 claims 1
- 108700012359 toxins Proteins 0.000 claims 1
- 230000007704 transition Effects 0.000 claims 1
- 210000002700 urine Anatomy 0.000 claims 1
- 239000003302 ferromagnetic material Substances 0.000 abstract description 7
- 230000015572 biosynthetic process Effects 0.000 abstract description 4
- 230000001419 dependent effect Effects 0.000 abstract 2
- 239000002245 particle Substances 0.000 description 14
- 229920002307 Dextran Polymers 0.000 description 10
- 230000004044 response Effects 0.000 description 7
- 108010062580 Concanavalin A Proteins 0.000 description 6
- 229920002684 Sepharose Polymers 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000006249 magnetic particle Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 241001233242 Lontra Species 0.000 description 1
- 239000012042 active reagent Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 238000009614 chemical analysis method Methods 0.000 description 1
- 230000009137 competitive binding Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 239000006148 magnetic separator Substances 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Materials By The Use Of Magnetic Means (AREA)
Abstract
Description
520 1so~"““_ ' ' n n. 0 Analyser kan göras på analyter (A), vilka har låg magnetisk permeabilitet (ulæl) varvid en analytbindande markör (B) med en tillräckligt stor magnetisk perrneabilitet (ur>>l) tillåts binda (kovalent eller icke-kovalent) till analyten, antigen före eller efter analytens inbindning till igenkänningskomponenten (I), och således inducerar mätbara lokala förändringar av materialkonstanten (ur) beroende på bildandet av ett komplex mellan analyten (kopplad till markören) och igenkänningskomponenten. 520 Analyzes can be performed on analytes (A) which have low magnetic permeability (ulel) allowing an analyte binding marker (B) with a sufficiently large magnetic permeability (ur >> l). bind (covalently or non-covalently) to the analyte, antigen before or after the binding of the analyte to the recognition component (I), and thus induce measurable local changes in the material constant (ur) due to the formation of a complex between the analyte (linked to the marker) and the recognition component.
Den analytbindande markören (B) innehåller dels ett ferromagnetiskt material (M) och dels en bindande substans (C) som riktas mot en annan epitop på analyten än den igenkänningskomponenten (I) är riktad emot. Se figur lb.The analyte binding marker (B) contains both a ferromagnetic material (M) and a binding substance (C) which is directed towards a different epitope on the analyte than the recognition component (I) is directed towards. See figure lb.
~ Analyser kan göras på analyter (A), vilka har låg magnetisk permeabilitet (ur: 1) varvid en analytliknande markör (E) med en tillräckligt stor magnetisk permeabilitet (ur>>l) tillåts att vid ett med analyten (A) kompetitivt förfarande binda till igenkänningskomponenten (I) och således inducera mätbara lokala förändringar av materialkonstanten (ur) beroende på bildandet av ett komplex (A-I eller B-l) mellan analyten (A) eller markören (B) och igenkänningskomponenten (I). Den analytliknande markören (B) innehåller dels ett ferromagnetiskt material (M) och dels en substans (D) som är analyt (A) eller en analytliknande substans som kan tävla om inbindingen till igenkänningskomponenten (I). Se ñgur le.~ Analyzes can be performed on analytes (A), which have low magnetic permeability (ur: 1) whereby an analyte-like marker (E) with a sufficiently large magnetic permeability (ur >> l) is allowed to in a process competitive with the analyte (A) bind to the recognition component (I) and thus induce measurable local changes in the material constant (ur) due to the formation of a complex (AI or B1) between the analyte (A) or the marker (B) and the recognition component (I). The analyte-like marker (B) contains both a ferromagnetic material (M) and a substance (D) which is analyte (A) or an analyte-like substance which can compete for binding to the recognition component (I). Se ñgur le.
Den magnetiska permeabilíteten för materialet inuti och i närheten av en spole eller ledare påverkar dess induktans. Detta gör att induktansmätningar möjliggör bestämningar av magnetisk perrneabilitet, vilket i vått fall leder till att halten analyt kan kvantifieras. Detta kan göras genom att den magnetiska permeabiliteten mäts på igenkänningskomponenten (eventuellt inklusive matrisen den är immobiliserad till) direkt. Ett mera indirekt tillvägagångssätt innebär en mätning av minskningen i magnetisk penneabilitet i mätlösningen beroende på att en del av analyten eller markören fastnar p g a molekylära igenkänningen på igenkänningskomponenten.The magnetic permeability of the material inside and near a coil or conductor affects its inductance. This means that inductance measurements enable determinations of magnetic permeability, which in wet cases leads to the content of analyte being quantifiable. This can be done by measuring the magnetic permeability of the recognition component (possibly including the matrix to which it is immobilized) directly. A more indirect approach involves measuring the decrease in magnetic peneability in the measurement solution due to a portion of the analyte or marker adhering due to the molecular recognition on the recognition component.
Induktansen för en lång spole bestäms av ekvationen: L=(uA/l) N 2 (generellt inne i spolen) där u betecknar den magnetiska permeabiliteten, l betecknar spolens längd, A betecknar spolens tvärsnittsarea och N är antalet líndade varv på spolen. Således om A, l och N hâlles konstanta, samt om en kontrollerad mängd material befinner sig inne i spolen kan den magnetiska permeabiliteten för detta material bestämmas.The inductance of a long coil is determined by the equation: L = (uA / l) N 2 (generally inside the coil) where u denotes the magnetic permeability, l denotes the length of the coil, A denotes the cross-sectional area of the coil and N is the number of wound turns on the coil. Thus, if A, 1 and N are kept constant, and if a controlled amount of material is inside the coil, the magnetic permeability of this material can be determined.
Induktansen kan mätas på flera olika sättlß: * Genom att spolen placeras i en elektrisk mätbrygga, t.ex. en Maxwellbrygga.The inductance can be measured in several different ways: * By placing the coil in an electrical measuring bridge, e.g. a Maxwell jetty.
* Genom att mäta resonansfrekvensen hos en LC-krets i vilken spolen ingår.* By measuring the resonant frequency of an LC circuit in which the coil is included.
* Genom att applicera en potential puls och mäta strömsvaret.* By applying a potential pulse and measuring the current response.
* Genom att applicera en ström puls eller en icke-konstant ström (där strömförändringen per tidsenhet di/dt hålles konstant) och spänningssvaret studeras.* By applying a current pulse or a non-constant current (where the current change per unit time di / dt is kept constant) and the voltage response is studied.
* Genom induktiv koppling mellan två spolar.* By inductive connection between two coils.
* Genom att mäta spolens impedans. 520 150 Q gj, _' ; ' , L , , _ . . .* By measuring the impedance of the coil. 520 150 Q gj, _ '; ', L,, _. . .
Magnetism har använts för speciñk isolering i industriell skala, t.ex. den s.k. HGMS- tekniken (High Gradient Magnetic Separator) som används i samband med stora processer, såsom vattenrening, bearbetning av kaolin m m, samt cell/protein isolering med magnetiskt påverkbara partiklar (t ex av fabrikatet Dynal). Det finns på marknaden även induktiva givare, som bygger på att en spole fångar upp en magnetfältsändring. Dessa induktiva givare reagerar på fysikaliska egenskaper t.ex. att en flottör i en tank förses med en magnet eller ett ferromagnetiskt material. Den induktiva givaren reagerar således på tankens vätskenivå.Magnetism has been used for specific insulation on an industrial scale, e.g. the s.k. The HGMS technology (High Gradient Magnetic Separator) which is used in connection with large processes, such as water purification, processing of kaolin etc., as well as cell / protein insulation with magnetically actuable particles (eg from the manufacturer Dynal). There are also inductive sensors on the market, which are based on a coil capturing a magnetic field change. These inductive sensors react to physical properties e.g. that a fl otter in a tank is provided with a magnet or a ferromagnetic material. The inductive sensor thus reacts to the liquid level of the tank.
Tidigare känt är ett stort antal patentskrifter, vilka innefattar mätningar av magnetiska fält eller magnetisk perineabilitet för bestämning av innehållet av magnetiskt material i ett prov, såsom tex. magnetit i järnmalm, jämoxid i slagg, halten katalytiskt aktivt nickel vid hydrogenering av fett, hårdinetallegerings kontroll, järninnehållet i oljor, detektion av paramagnetiska joner, ferromagnetiska material i cementblandningar, samt magnetiska syrgas analysatorer. Vid dessa bestämningar sker ingen molekylär igenkänning av analyten, vilket bidrar till en oftast låg specificitet och att analysen blir starkt begränsad till ferromagnetiska material. Nämnas kan även följande patentskrifter: Magnetisla aktiva reagentbärare [se patent US 6674l4]: Dessa är användbara för transport av antikroppar, enzymer eller haptener, vid tex. immunoassayer. Skriften berör endast användandet av bäraren såsom ett medel för isolering eller upgrening och det föreslås att detta kan kombineras med andra kemiska analystekniker. Dock berörs överhuvudtaget inte mätningar av den magnetiska permeabiliteten på bärarpartiklarna per se. Det samma gäller en annan patentskrift [se patent JP 62118255 A], där magnetiska partiklar användes på ett dylikt sätt för kemisk analys, varvid själva mätningen sker med hjälp av ljusspridningsfenomen.Previously known are a large number of patents, which include measurements of magnetic fields or magnetic perineability for determining the content of magnetic material in a sample, such as e.g. magnetite in iron ore, iron oxide in slag, the catalytically active nickel content in hydrogenation of grease, hard metal alloy control, the iron content in oils, detection of paramagnetic ions, ferromagnetic materials in cement mixtures, and magnetic oxygen analyzers. In these determinations, there is no molecular recognition of the analyte, which contributes to an often low specificity and that the analysis is severely limited to ferromagnetic materials. Mention may also be made of the following patents: Magnetisla active reagent carriers [see patent US 667414]: These are useful for the transport of antibodies, enzymes or haptens, in e.g. immunoassayer. The document only relates to the use of the carrier as a means of isolation or branching and it is suggested that this may be combined with other chemical analysis techniques. However, measurements of the magnetic permeability of the carrier particles per se are not affected at all. The same applies to another patent specification [see patent JP 62118255 A], where magnetic particles are used in such a way for chemical analysis, whereby the measurement itself takes place by means of light scattering phenomena.
Mätning av magetfältsändringgr har rapporterats tidigare bl.a. i kombination med magnetotaktiska bakterier för förutsägelse av hypoxi i vatten [se patent US 7873031: Denna patentskriñ behandlar magnetfâltsmätriingar på magnetiskt anrikade lager av bakterier innehållande magnetiska partiklar. Mängden sådana bakterier i lagret (som bidrager till magnetfaltets styrka) korrelerar till syrgashalten i den omgivande miljön.Measurement of gastric field changegr has been reported previously i.a. in combination with magnetotactic bacteria for the prediction of hypoxia in water [see patent US 7873031: This patent specification deals with magnetic field measurements on magnetically enriched layers of bacteria containing magnetic particles. The amount of such bacteria in the layer (which contributes to the strength of the magnetic field) correlates to the oxygen content in the surrounding environment.
Vidare har nyligen ett arbete publicerats beskrivande biomagnetiska neurosensorer4. Även detta arbete bygger på mätningar av magnetfält, som i detta fall beror på jonvandringar (vilka motsvarar en elektrisk ström som ger upphov till ett inducerat magnetfält) i en nerv. således är det fråga om en helt annan typ av detektion, där det inte rör sig om mätningar av en materialkonstant, som i vårt fall. Det bör även påpekas att magnetfälts mätningar är känsliga för störningar av den stora mängd elektroniskt brus som finns runt omkring oss. Vidare kan endast ämnen som påverkar nerven respektive bakterier detekteras och svaret kan vara mycket svårtolkat och komplext.Furthermore, a work has recently been published describing biomagnetic neurosensors4. This work is also based on measurements of magnetic fields, which in this case are due to ion migrations (which correspond to an electric current that gives rise to an induced magnetic field) in a nerve. thus, it is a question of a completely different type of detection, where it is not a question of measurements of a material constant, as in our case. It should also be pointed out that magnetic field measurements are sensitive to interference from the large amount of electronic noise that exists around us. Furthermore, only substances that affect the nerve or bacteria can be detected and the response can be very difficult to interpret and complex.
För att raktiskt exem lifiera det av oss föreslagna n a förfarandet i denna P . p. . ~ Y. patentansökan, redovisar vi nedan resultat från gjorda förstudier.To practically eczema live the n a procedure proposed by us in this P. p. ~ Y. patent application, we report below results from preliminary studies.
Ett exempel på en användbar rnarlcör och bestämningen av denna: För att exemplifiera med en möjlig markör valde vi att använda speciella järnoxid-dextran partiklar, vilka uppvisar en stor magnetisk permeabilitet. Partiklarna är dock så små (uppskattningsvis 1-300 nm) att lösningen är kolloid och dextranhöljet (i kombination med att partiklarna har en låg magnetisk rernanens) medverkar till att ingen 520 150 ¿~» aggregering av partiklarna sker. Mätningar av den magnetiska permeabiliteten på lösningar innehållande olika koncentrationer av sådana partiklar utfördes.An example of a useful marker and its determination: To exemplify with a possible marker, we chose to use special iron oxide-dextran particles, which exhibit a large magnetic permeability. However, the particles are so small (approximately 1-300 nm) that the solution is colloidal and the dextran sheath (in combination with the particles having a low magnetic retention) contributes to no aggregation of the particles. Measurements of the magnetic permeability of solutions containing different concentrations of such particles were performed.
Lösningama placerades i en mätspole vars induktans påverkades och i sin tur inverkade på antingen resonansfrekvensen (se figur 2) för en LC-krets i vilken spolen ingick eller på balanseringen (se figur 3), uttryckt som en spänningsskillnad (respons), av en Maxwell brygga i vilken spolen ingick. Av de båda figurerna (2 och 3) framgår att sambandet mellan utsignal (resonansfrekvens ändring i Hz eller spänningsskillnad (respons) i mV) står i ett linjärt samband med halten partiklar i mätlösningen (uttryckt i form av koncentrationen jäm). Detta exempel illustrerar att det är fullt möjligt att använda de beskrivna teknikema, baserade på mätningar av magnetisk permeabilitet, för att bestämma halten markör/analyt vilket är användbart om bestämningar av markörhalts-lanalythalts-minskningen i mätlösningen skall bestämmas.The solutions were placed in a measuring coil whose inductance was affected and in turn affected either the resonant frequency (see Figure 2) of an LC circuit in which the coil was included or the balancing (see Figure 3), expressed as a voltage difference (response), by a Maxwell bridge in which the coil was included. From the two figures (2 and 3) it appears that the relationship between output signal (resonant frequency change in Hz or voltage difference (response) in mV) is in a linear relationship with the content of particles in the measurement solution (expressed in the form of the concentration even). This example illustrates that it is quite possible to use the described techniques, based on measurements of magnetic permeability, to determine the level of marker / analyte, which is useful if determinations of the marker content-lanalithium decrease in the measurement solution are to be determined.
Exempel på en kemisk analys av en modellanalyt vilken per se har en tillräckligt stor magnetisk permeabilitet: I detta delförsök valde vi att använda järnoxid-dextran partiklarna såsom en modellanalyt för analyter vilka per se har en tillräckligt stor magnetisk permeabilitet för att en bestämning, utan markörer, skall vara möjlig.Example of a chemical analysis of a model analyte which per se has a sufficiently large magnetic permeability: In this sub-experiment we chose to use the iron oxide-dextran particles as a model analyte for analytes which per se have a sufficiently large magnetic permeability for a determination, without markers , shall be possible.
Concanavalin A valdes som igenkänningskomponent (eftersom den binder till dextran) och immobiliserades till en bärare (sepharos gel / Pharmacia). Efter inkubering i mätlösningar innehållande olika halt av modellanalyt användes Maxwellbrygge- principen, beskriven tidigare, för analys av den magnetiska penneabiliteten hos det bildade komplexet. Av figur 4 framgår att spänningsskillnaden (responsen) (övre kurvan) ökar med ursprungshalten modellanalyt i mätlösningen (uttryckt i form av koncentrationen järn). Då samma försök utfördes på en bärare utan Concanavalin A noterades inga spänningsskillnader (undre kurvan). Detta bestyrker vikten av den molekylära igenkänningen för den kemiska analysen.Concanavalin A was selected as a recognition component (because it binds to dextran) and immobilized on a carrier (sepharose gel / Pharmacia). After incubation in measurement solutions containing different contents of model analyte, the Maxwellbrygge principle, described earlier, was used to analyze the magnetic penile stability of the complex formed. Figure 4 shows that the voltage difference (response) (upper curve) increases with the original content of model analyte in the measurement solution (expressed in the form of the concentration of iron). When the same experiment was performed on a carrier without Concanavalin A, no voltage differences were noted (lower curve). This confirms the importance of the molecular recognition for the chemical analysis.
Exempel på en kemisk analys av en analyt (glukos), som har låg magnetisk permeabilitet (urr-l). genom ett kompetitivt förfarande mellan analyten och en markör: I detta delförsök visar vi att det är möjligt att kvantitativt och kvalitativt mäta halten av en analyt, som har låg magnetisk perrneabilitet (ul-el). Vi valde som modell att använda glukos som analyt, järnoxid-dextran partiklar (beskrivna ovan) som den kompetitiva markören och Concanavalin-A som igenkänningskomponenten. Concanavalin-A var immobiliserad till en bärare (sepharos gel / Pharmacia). Eftersom glukos och markören (via sin dextran komponent) båda har affinitet för Concanavalin-A tävlade dessa om inbindningen till denna. Vid låga halter eller i frånvaro av glukos binder endast markören till igenkänningskomponenten. Med ökande halt glukos i mätlösningen utgörs en allt mindre andel av de båda inbundna substanserna (glukos respektive markör) till igenkänningskomponenten av markören. Således är det möjligt att på detta sätt bestämma glukos koncentrationen i ett okänt prov. Genom att placera igenkänningskomponenten Concanavalin-A inuti spolen kunde mängden inbunden markör detekteras för olika glukoskoncentrationer. Resultatet finns avbildat i figur 5.Example of a chemical analysis of an analyte (glucose), which has low magnetic permeability (urr-1). by a competitive procedure between the analyte and a marker: In this sub-experiment we show that it is possible to quantitatively and qualitatively measure the content of an analyte, which has low magnetic perneability (ul-el). We chose as a model to use glucose as analyte, iron oxide-dextran particles (described above) as the competitive marker and Concanavalin-A as the recognition component. Concanavalin-A was immobilized on a vehicle (sepharose gel / Pharmacia). Because glucose and the marker (via their dextran component) both have affinity for Concanavalin-A, they competed for binding to it. At low levels or in the absence of glucose, only the marker binds to the recognition component. With increasing glucose content in the measurement solution, an ever smaller proportion of the two bound substances (glucose and marker respectively) to the recognition component of the marker is constituted. Thus, it is possible in this way to determine the glucose concentration in an unknown sample. By placing the recognition component Concanavalin-A inside the coil, the amount of bound marker could be detected for different glucose concentrations. The result is depicted in Figure 5.
Av denna kalibreringskurva för glukosanalys framgår att spänningsskillnaden hos Maxwellbryggan, kompenserad för maximal inbindning av markör, (responsförändring) står i samband med glukoshalten i mätlösningen (övre kurvan).From this calibration curve for glucose analysis it appears that the voltage difference of the Maxwell bridge, compensated for the maximum binding of the marker, (response change) is related to the glucose content in the measurement solution (upper curve).
Kontrollförsöket utan igenkänningskomponent bekräftar att frånvaron av molelcylär igenkänning medför att detta samband uteblir (undre kurvan). Vi lyckades även att utföra mätningar på glukos med igenkännigkomponenten immobiliserad inuti spolen, varvid alltså en kemisk (bio)senor för glukos demonstrerades. 520 2 LITTERATUR REFEREiNSEilš i 150 112* 5 ,¥' .' --r_.-'-V ¿'I 1. E. Dj urle, Electricitetslära, Teknisk Högskolelitteratur i Stockholm AB, 1983 2. D. Kriz, Towards chemical sensors, Lund 1994 3. L. Grahm, H.-G. J ubrink och A. Lauber, Elektrisk mätteknik 1 & 2, Bokförlaget teknikinforxnation, Lund och Linköping 1992. 4. Christopher W. Babb, David R. Coon, Garry A. Rechnitz, Anal. Chem., 1995, 67, 763-769. ' .i = ~“ c=' l ' 520150 gi :a 'f ' y :ax fl i g ;:*' .. 25 .i t 3 F IGURTEXTER Figur 1. Tre olika varianter (a, b och c) av ett mättörfarande byggande på kombinationen molekylär igenkánning och mätning av magnetisk pezmeabilitet.The control experiment without recognition component confirms that the absence of molecular recognition means that this connection is missing (lower curve). We also managed to perform measurements on glucose with the recognition component immobilized inside the coil, thus demonstrating a chemical (bio) tendon for glucose. 520 2 LITERATURE REFEREINSEilš i 150 112 * 5, ¥ '.' --r _.-'- V ¿'I 1. E. Dj urle, Electricitetslära, Teknisk Högskolelitteratur i Stockholm AB, 1983 2. D. Kriz, Towards chemical sensors, Lund 1994 3. L. Grahm, H.-G. J ubrink and A. Lauber, Elektrisk mätteknik 1 & 2, Bokförlaget teknikinforxnation, Lund and Linköping 1992. 4. Christopher W. Babb, David R. Coon, Garry A. Rechnitz, Anal. Chem., 1995, 67, 763-769. '.i = ~ “c =' l '520150 gi: a' f 'y: ax fl ig;: *' .. 25 .it 3 F IGURTEXTER Figure 1. Three different variants (a, b and c) of a measurement procedure based on the combination of molecular recognition and measurement of magnetic pezmeability.
Figur 2. Resonansfrekvensmâtningar på mâtlösningar innehållande olika halt järnoxid-dextran partiklar (markör).Figure 2. Resonance frequency measurements on measurement solutions containing different contents of iron oxide-dextran particles (marker).
Figur 3. Maxwellbryggemätningar på mätlösningar innehållande olika halt järnoxid-dextran partiklar (markör).Figure 3. Maxwell bridge measurements on measuring solutions containing different contents of iron oxide-dextran particles (marker).
Figur 4. Maxwellbryggemâtningar på concanawalin-A sepharose (igenkänningskomponent-bärare) som har inkuberats i mâtlösningar innehållande olika halt jämoxid-dextran partiklar (modellanalyt).Figure 4. Maxwell bridge measurements on concanawalin-A sepharose (recognition component carrier) that have been incubated in measurement solutions containing different levels of iron oxide-dextran particles (model analyte).
Figur 5. Maxwellbryggemätningar på concanaxalin-A . sepharose (igenkänningskomponent-bärare) som har inkuberats i mâtlösningar innehållande olika halt glukos (modellanalyt) och konstant halt järnoxid-dextran partiklar (rnarkör), och där en kompetitiv inbindning har skett.Figure 5. Maxwell bridge measurements on concanaxaline-A. sepharose (recognition component carrier) which has been incubated in measurement solutions containing different levels of glucose (model analyte) and constant levels of iron oxide-dextran particles (core), and where a competitive binding has taken place.
Claims (10)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9502902A SE520150C2 (en) | 1995-08-20 | 1995-08-20 | Quantitative and qualitative analysis of chemical substances |
| US08/847,125 US6110660A (en) | 1995-08-20 | 1997-05-01 | Procedure for quantitative and qualitative determination of chemical substances, based on molecular recognition and measurement of magnetic permeability |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9502902A SE520150C2 (en) | 1995-08-20 | 1995-08-20 | Quantitative and qualitative analysis of chemical substances |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE9502902D0 SE9502902D0 (en) | 1995-08-20 |
| SE9502902L SE9502902L (en) | 1997-02-21 |
| SE520150C2 true SE520150C2 (en) | 2003-06-03 |
Family
ID=20399240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE9502902A SE520150C2 (en) | 1995-08-20 | 1995-08-20 | Quantitative and qualitative analysis of chemical substances |
Country Status (1)
| Country | Link |
|---|---|
| SE (1) | SE520150C2 (en) |
-
1995
- 1995-08-20 SE SE9502902A patent/SE520150C2/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| SE9502902D0 (en) | 1995-08-20 |
| SE9502902L (en) | 1997-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101046464B (en) | Sensor element and detection method of magnetic particles, and detection method of target substance | |
| Li et al. | AC electrokinetics-enhanced capacitive immunosensor for point-of-care serodiagnosis of infectious diseases | |
| US6110660A (en) | Procedure for quantitative and qualitative determination of chemical substances, based on molecular recognition and measurement of magnetic permeability | |
| US20100120016A1 (en) | Methods and systems for detection of contaminants | |
| RU2444736C2 (en) | Target molecule detection in sample | |
| RU2456618C2 (en) | System and method for detection using magnetic and/or electric label | |
| EP2503335A2 (en) | Method and device for detecting analytes | |
| CN1249672A (en) | Method and apparatus for detecting magnetically responsive substance | |
| US20120244630A1 (en) | Multiplexed analyte concentration measurement | |
| Song et al. | A rapid immunomagnetic beads-based immunoassay for the detection of β-casein in bovine milk | |
| Meyer et al. | Francisella tularensis detection using magnetic labels and a magnetic biosensor based on frequency mixing | |
| EP2694946A1 (en) | A device for detecting an analyte | |
| EP1488230B1 (en) | Drift compensated magnetic permeability detector | |
| Larsson et al. | Magnetic transducers in biosensors and bioassays | |
| Shirzadfar et al. | Characterization of a needle-type giant magnetoresistance sensor for detection of escherichia coli’s magnetic marker | |
| JP5188091B2 (en) | Sensor element, magnetic particle detection method using the element, and target substance detection method | |
| David et al. | Assessment of pathogenic bacteria using periodic actuation | |
| CN101438162A (en) | Accurate magnetic biosensor | |
| CN112415079B (en) | A dual-parameter self-validating homogeneous immunoassay method for single particle inductively coupled plasma mass spectrometry | |
| CN101313217A (en) | Sensitive magnetic catch assay by building a strong binding couple | |
| Hecht et al. | Label-acquired magnetorotation as a signal transduction method for protein detection: aptamer-based detection of thrombin | |
| Endo et al. | Development of a label-free immunosensor system for detecting oocyte maturation-inducing hormone in fish | |
| SE520150C2 (en) | Quantitative and qualitative analysis of chemical substances | |
| Ando et al. | Residence times difference fluxgate magnetometer for magnetic biosensing | |
| Sun et al. | An innovative detecting way of Escherichia coli O157H: H7 by a micro-fluxgate-based bio-sensing system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |